Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States)

被引:96
作者
Ngo, TH
Barnard, RJ
Tymchuk, CN
Cohen, P
Aronson, WJ
机构
[1] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA
关键词
apoptosis; dietary fat; IGF-I axis; physical activity; prostate cancer;
D O I
10.1023/A:1021911517010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Accumulating evidence indicates that prostate cancer is associated with high levels of serum IGF-I. This study was conducted to determine whether a low-fat diet and exercise (DE) intervention may modulate the IGF axis and reduce prostate cancer cell growth in vitro. Methods: Fasting serum was obtained from 14 men (age 60 +/- 3 years) participating in an 11-day DE program and from eight similarly aged men who had followed the DE program for 14.2 +/- 1.7 years (long-term). Insulin, IGF-I, IGFBP-1, and IGFBP-3 were measured by ELISA, and serum was used to stimulate LNCaP cell growth in vitro. Results: Serum IGF-I levels decreased by 20% while IGFBP-1 increased by 53% after 11-day DE. In the long-term group, IGF-I was 55% lower, while IGFBP-1 was 150% higher relative to baseline. Serum insulin decreased by 25% after 11-day DE and was 68% lower in the long-term group, relative to baseline. No changes in serum IGFBP-3 were observed. Serum-stimulated LNCaP cell growth was reduced by 30% in post-11-day serum and by 44% in long-term serum relative to baseline. LNCaP cells incubated with post-DE serum showed increased apoptosis/necrosis, compared to baseline. Conclusions: A low-fat diet and exercise intervention induces in-vivo changes in the circulating IGF axis and is associated with reduced growth and enhanced apoptosis/necrosis of LNCaP tumor cells in vitro.
引用
收藏
页码:929 / 935
页数:7
相关论文
共 40 条
[1]   ROLE OF DIET AND EXERCISE IN THE MANAGEMENT OF HYPERINSULINEMIA AND ASSOCIATED ATHEROSCLEROTIC RISK-FACTORS [J].
BARNARD, RJ ;
UGIANSKIS, EJ ;
MARTIN, DA ;
INKELES, SB .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (05) :440-444
[2]   What causes prostate cancer? A brief summary of the epidemiology [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, EL .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (04) :263-273
[3]   Plasma insulin-like growth factor I and prostate cancer risk: A prospective study [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, E ;
Gann, PH ;
Ma, J ;
Wilkinson, P ;
Hennekens, CH ;
Pollak, M .
SCIENCE, 1998, 279 (5350) :563-566
[4]   THE IGF AXIS IN THE PROSTATE [J].
COHEN, P ;
PEEHL, DM ;
ROSENFELD, RG .
HORMONE AND METABOLIC RESEARCH, 1994, 26 (02) :81-84
[5]   Serum insulin-like growth factor-I levels and prostate cancer risk - Interpreting the evidence [J].
Cohen, P .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :876-879
[6]   Does the GH-IGF axis play a role in cancer pathogenesis? [J].
Cohen, P ;
Clemmons, DR ;
Rosenfeld, RG .
GROWTH HORMONE & IGF RESEARCH, 2000, 10 (06) :297-305
[7]   The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action [J].
CollettSolberg, PF ;
Cohen, P .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (03) :591-&
[8]   INSULIN REGULATION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 IN OBESE AND NONOBESE HUMANS [J].
CONOVER, CA ;
LEE, PDK ;
KANALEY, JA ;
CLARKSON, JT ;
JENSEN, MD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (06) :1355-1360
[9]   LACK OF GROWTH-HORMONE EFFECT ON INSULIN-ASSOCIATED SUPPRESSION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 IN HUMANS [J].
CONOVER, CA ;
BUTLER, PC ;
WANG, M ;
RIZZA, RA ;
LEE, PDK .
DIABETES, 1990, 39 (10) :1251-1256
[10]   Cellular actions of insulin-like growth factor binding proteins [J].
Ferry, RJ ;
Katz, LEL ;
Grimberg, A ;
Cohen, P ;
Weinzimer, SA .
HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) :192-202